CLINICAL_TRIALS
trial_result
· 2015-05-13
Clinical Trial Update: Topical Nepafenac as Supplement for Diabetic Macular Edema [Phase 4]
Summary
A Phase 4 clinical trial evaluating topical nepafenac as an adjunct treatment for diabetic macular edema has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Universiti Sains Malaysia | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED